Sanofi SA
NASDAQ:SNY

Watchlist Manager
Sanofi SA Logo
Sanofi SA
NASDAQ:SNY
Watchlist
Price: 48.23 USD -0.47% Market Closed
Market Cap: 120.5B USD

Relative Value

The Relative Value of one SNY stock under the Base Case scenario is hidden USD. Compared to the current market price of 48.23 USD, Sanofi SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SNY Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
39
Median 3Y
2.6
Median 5Y
2.7
Industry
2.6
Forward
2.2
vs History
95
vs Industry
21
Median 3Y
15
Median 5Y
16.4
Industry
21.4
Forward
10.4
vs History
96
vs Industry
27
Median 3Y
11
Median 5Y
11.6
Industry
16.4
vs History
57
vs Industry
21
Median 3Y
18.5
Median 5Y
20
Industry
22.8
vs History
96
vs Industry
45
Median 3Y
1.5
Median 5Y
1.6
Industry
2.2
vs History
96
vs Industry
37
Median 3Y
2.8
Median 5Y
2.9
Industry
2.9
Forward
2.3
vs History
96
vs Industry
45
Median 3Y
4
Median 5Y
4.1
Industry
5.5
vs History
96
vs Industry
33
Median 3Y
9.1
Median 5Y
9.6
Industry
13
Forward
7.5
vs History
96
vs Industry
30
Median 3Y
11.7
Median 5Y
13.3
Industry
16.5
Forward
9.1
vs History
93
vs Industry
26
Median 3Y
11.7
Median 5Y
12.3
Industry
15.6
vs History
93
vs Industry
15
Median 3Y
14.7
Median 5Y
15.8
Industry
18.7
vs History
77
vs Industry
47
Median 3Y
1.1
Median 5Y
1.1
Industry
1.9

Multiples Across Competitors

SNY Competitors Multiples
Sanofi SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Sanofi SA
NASDAQ:SNY
100.2B USD 1.5 7.3 6.6 6.6
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.9 30.2 108.3 158.6
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14.1 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
FR
Sanofi SA
NASDAQ:SNY
Average P/E: 22.4
7.3
26%
0.3
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.2
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Sanofi SA
NASDAQ:SNY
Average EV/EBITDA: 400.4
6.6
8%
0.8
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
1%
9.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Sanofi SA
NASDAQ:SNY
Average EV/EBIT: 1 712.7
6.6
15%
0.4
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5